NCT06061770

Brief Summary

This is a prospective, randomized, controlled, two parallel arms, single-blind pilot study. In this design, all included patients in the chronic phase of a stroke will receive both modes of physical activity. This study includes patients over 18 years of age with spastic hemiparesis sequelae of a first unilateral hemispheric stroke older than 6 months and able to walk for 6 minutes. The non-inclusion criteria were the inability to walk without human assistance (with or without technical aids), the existence of cognitive disorders compromising informed consent, in particular the inability to understand the objective and the modalities of the protocol, the inability to communicate with the examiners, and the presence of an additional neurological disorder or a pathology contraindicating the practice of physical activity. The primary endpoint is based on daily activity measurement by measuring the number of steps per day, collected over the duration of the study, via a Stepwatch™ device. Secondary end points involve a written physical activity report, assessment of walking ability (via walking-test 6, heart rate, and blood pressure), a measure of perceived exertion, stroke-specific quality of life, balance, and motivation to perform physical activity.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
10mo left

Started Sep 2024

Typical duration for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress65%
Sep 2024Mar 2027

First Submitted

Initial submission to the registry

September 18, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 29, 2023

Completed
12 months until next milestone

Study Start

First participant enrolled

September 27, 2024

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 26, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 26, 2027

Last Updated

February 5, 2026

Status Verified

February 1, 2026

Enrollment Period

2.2 years

First QC Date

September 18, 2023

Last Update Submit

February 3, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Daily activity measurement

    Measuring the number of steps per day, collected over the duration of the study, via a Stepwatch device

    through study completion

Secondary Outcomes (9)

  • the rate physical activities in Written report

    through study completion

  • 6-minute walk test (6MWT)

    at inclusion Day and at the 13th week (and the 26th week for one group only)

  • Measurement of heart rate at rest and after 6-minute walk test

    at inclusion Day and at the 13th week (and the 26th week for one group only)

  • Measurement of systolic blood pressure at rest and after 6-minute walk test

    at inclusion Day and at the 13th week (and the 26th week for one group only)

  • Borg Rating Scale of Exertion

    at inclusion Day and at the 13th week (and the 26th week for one group only)

  • +4 more secondary outcomes

Study Arms (2)

First APA program

EXPERIMENTAL

The evaluation of the primary endpoint to meet our main objective will be done at W13 for both groups. The addition of an APA program in autonomy following the structured program for group 1 will make it possible to answer a secondary question focusing on the comparison of the effectiveness of the self-directed program carried out alone or following a structured program. 1st group: D0: Include S1-S12: APA program at IUR Valmante S13: Break S14-S25: APA Autoprogram In addition, the patients in group 1 are maintained in the follow-up to study the maintenance of any observed effect.

Other: Adapted physical activity program

Second APA program

ACTIVE COMPARATOR

Our study design provides for compensatory participation in the structured program for patients in group 2, following the self-program. From an ethical point of view, this scheme allows all patients included in the structured APA program to benefit. 2nd group: D0: Include S1-S12: APA Autoprogram S13: End of study S14-S25: APA program at IUR Valmante compensatory

Other: Adapted physical activity self-program

Interventions

Rehabilitation

First APA program

Rehabilitation

Second APA program

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age greater than 18 years
  • Left or right spastic hemiparesis after a first hemorrhagic or ischemic unilateral stroke older than 6 months
  • Walking possible for 6 minutes

You may not qualify if:

  • Inability to walk without human assistance (with or without technical aids)
  • Cognitive impairment that compromises informed consent, including inability to understand the purpose and terms of the protocol
  • Inability to communicate
  • Presence of an additional neurological disorder
  • Medical conditions that contraindicate physical activity, such as an unbalanced cardiovascular or respiratory condition
  • Concurrent participation in another clinical research project

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Médecine Physique et de Réadaptation, CHU Hôpital Sainte Marguerite

Marseille, Bouches du Rhône, 13009, France

RECRUITING

Related Publications (1)

  • Satger E, Prieur-Blanc N, Viton JM, Auquier P, Bensoussan L, Cotinat M. Effectiveness of an institution-based adapted physical activity programme versus a home-based self-management programme for chronic poststroke adults: protocol for a randomised controlled study. BMJ Open. 2024 Jul 20;14(7):e084688. doi: 10.1136/bmjopen-2024-084688.

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 18, 2023

First Posted

September 29, 2023

Study Start

September 27, 2024

Primary Completion (Estimated)

December 26, 2026

Study Completion (Estimated)

March 26, 2027

Last Updated

February 5, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

Data sharing statements that meet these ICMJE requirements Individual pseudonymous data of participants may be available The data that may be shared are the individual data of the participants which underlie the results reported in this article, after de-identification (text, tables, figures and appendices).

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
Beginning 3 months and ending 3 years following article publication.
Access Criteria
For researchers who provide a methodologically sound proposal. Types of analyses: Achieve the objectives of the approved proposal. Proposals should be sent to maeva.cotinat@ap-hm.fr

Locations